EI
KURA icon

Ellevest Inc’s Kura Oncology KURA Stock Holding History

Ellevest Inc’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1
Closed -$12 – 1037
2023
Q1 		$12 Buy
+1
New +$12 ﹤0.01% 1857
2022
Q2 		– Sell
-123
Closed -$2K – 1539
2022
Q1 		$2K Hold
123
– – ﹤0.01% 1198
2021
Q4 		$2K Hold
123
– – ﹤0.01% 1170
2021
Q3 		$2K Buy
123
+118
+2,360% +$2.22K ﹤0.01% 1148
2021
Q2 		$0 Hold
5
– – ﹤0.01% 1345
2021
Q1 		$0 Sell
5
-27
-84% -$854 ﹤0.01% 1306
2020
Q4 		$1K Buy
32
+27
+540% +$949 ﹤0.01% 1074
2020
Q3 		$0 Buy
+5
New +$110 ﹤0.01% 1229

Other funds holding KURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Ellevest Inc's KURA Position: Q2 2023 in Review

Ellevest Inc sold out of Kura Oncology (KURA) in Q2 2023, closing a stake of 1 share — an estimated $12 sold.

Ellevest Inc first reported a position in KURA in Q3 2020 and held it in 8 quarters. The position peaked at $2K in Q1 2022. 148 funds tracked by Wall St. Rank hold KURA as of Q2 2023.

  • Ellevest Inc reported no remaining Kura Oncology position as of Q2 2023 after selling out during the quarter.
  • Ellevest Inc sold 1 Kura Oncology share in Q2 2023, an estimated $12.
  • Ellevest Inc first reported a position in Kura Oncology in Q3 2020 and held it in 8 quarters.
  • Ellevest Inc's Kura Oncology position peaked at $2K in Q1 2022.
  • 148 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.